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Summary 
The bcl-2 gene encodes an intracellular, membrane-associated protein that protects immature cortical 
thymocytes from a wide variety of apoptotic stimuli, including glucocorticoids, radiation, and 
anti-CD3 treatment. Since cortical thymocytes are the primary target cells for thymic positive 
and negative selection processes, and since these processes are associated with cell death, we evaluated 
the role of bcl-2 in T cell development in two ways. In the first approach, transgenic mice expressing 
high levels of Bcl-2 in cortical thymocytes were mated with H-Y T cell receptor (TCR) transgenic 
mice, the latter being a well-defined system for the study of positive and negative selection of 
T cells. We found that the bcl-2 transgene had a dramatic effect on positive selection. This was 
manifested by a greatly increased production of mature thymocytes that were highly skewed 
towards the CD4-8 + lineage. The change involving CD4-8 § thymocytes occurred not only 
in bcl-2 transgenic mice, but was also observed in H-Y TCR/bcl-2 doubly transgenic mice, regardless 
of whether  the  H-Y  TCR  was  expressed  in  the  selecting  (H-2 b)  or  nonselecting  (1-1-2  d) 
environments. Furthermore, a large proportion of CD4-8 § thymocytes produced in H-2 b H-Y 
TCR/bcl-2  doubly transgenic female mice expressed endogenous TCR ot chains rather than the 
transgenic TCR ot chain. These observations are consistent with the model that high expression 
of Bcl-2 in cortical thymocytes overrides the normal apoptotic pathway. This then allows  the 
selection of CD4- 8 § thymocytes expressing TCRs that are otherwise nonselectable. However, 
the bcl-2 transgene did not protect CD4 +  8 + thymocytes expressing the male-specific TCR from 
deletion in male doubly transgenic mice. In the second approach, we determined the level of 
bcl-2 mRNA expression in populations of thymocytes defined by their CD4/CD8 phenotypes 
using quantitative reversed transcriptase PCIL techniques. Our results indicate that bcl-2 mRNA 
was  expressed  at  a  high  level  in  immature  CD4-8-  thymocytes and  in  mature  CD4§  - 
thymocytes. There is  a  dramatic downregulation of bcl-2 mRNA  in  CD4+8 +  thymocytes, 
particularly those expressing a low level of TCR.  CD4+8 + thymocytes that upregulated their 
TCR,  likely as a result of receiving positive selection signals,  also upregulated bcl-2 mP,  NA. 
This observation suggests that rescue of immature thymocytes from the programmed cell death 
pathway by positive selection signals  is accompanied by the upregulation of bcl-2 mRNA. 
T 
he development of T  cells in the thymus is associated 
with  the production  of large  numbers  of immature 
thymocytes that are subjected to thymic selection processes 
(1). Positive selection refers to the development of a mature 
T  cell repertoire that recognizes foreign antigenic peptides 
which are presented by self-MHC molecules. Negative selec- 
tion refers to the elimination ofT cells that are immunocompe- 
tent against self-antigenic peptides presented by selfoMHC 
molecules. The primary target for positive and negative se- 
lection appears  to be the immature CD4+8 + thymocytes, 
which express a low level of the TCtL-ot/3  (2).  CD4+8 + 
thymocytes are produced daily in large numbers and have an 
average life span of 3.5 d (3). Since the TCR repertoire ex- 
pressed by CD4+8 + thymocytes is generated in a random 
manner, only a very minor fraction of these cells is expected 
to express TCR of sufficient affinity for positively and nega- 
tively selecting ligands. Thus, the vast majority of CD4 +  8 + 
thymocytes are predicted to express nonselectable TCR. and 
145  J. Exp. Med. ￿9  The Rockefeller  University  Press ￿9 0022-1007/94/01/0145/09 $2.00 
Volume 179  January 1994  145-153 are postulated to undergo a form of programmed cell death 
(PCD) t (1,  2).  Cell death induced by negative selection  is 
a TCK-mediated process and occurs rapidly since CD4 +  8 + 
thymocytes expressing a TCR of defined specificity are deleted 
within hours of interacting with the deleting ligand (4-6). 
This form of cell death is dependent upon TCR-ligand in- 
teraction and it has also been referred to as activation-induced 
cell death (AICD). It is clear from these considerations that 
interference with the death pathways of thymocytes, particu- 
larly those associated  with PCD  and AICD,  are likely to 
influence the outcome of thymic selection processes. 
The bcl-2 protooncogene, which encodes  an intracellular 
membrane protein, was discovered as a result of its transloca- 
tion to the Ig locus in human follicular center B cell lym- 
phoma (7-12). This t(14; 18) chromosomal translocation spares 
the coding region of the bcl-2 gene and appears to deregulate 
its expression.  Enforced bcl-2 expression delays the death of 
certain hematopoietic cell lines deprived of growth factors 
(13). Moreover, transgenic mice expressing a bcl-2 gene under 
the control of the Ig H chain enhancer contain a large excess 
of B cells that are adapted for long-term survival in vitro and 
in vivo (14-17). The Bd-2 protein is expressed in specific areas 
of the thymus, being present in medullary but not most cor- 
tical thymocytes (18). Since the majority of CD4+8 § cor- 
tical thymocytes are destined for PCD the lack of Bcl-2 in 
these cells suggests that Bcl-2 may be involved in the salva- 
tion of T  cells. 
To assess the role of bcl-2 in T cell development, transgenic 
mice were generated in which bcl-2 expression was redirected 
to the immature T cells in the thymic cortex using the prox- 
imal promoter of the lck tyrosine kinase gene (Ick Pr) (19). In 
these kkPr-bcl-2  transgenic mice, total thymocyte numbers 
were normal, suggesting that a substantial amount of cell 
death was still occurring (19). However, the expression  of 
Bcl-2 in cortical thymocytes protected them from a wide va- 
riety of apoptotic stimuli including glucocorticoids, radia- 
tion, and anti-CD3 treatment (19-21).  Examination of the 
V~ repertoires  in these mice indicated that deletion of T cells 
with reactivity towards self-superantigens  still occurred, thus 
suggesting that negative selection was Bcl-2 independent (19). 
Furthermore, deregulated bcl-2 expression led to the produc- 
tion of larger numbers of T cells having a mature phenotype 
(19). Similar results were obtained in transgenic mice where 
the bcl-2 gene was regulated by the Ig H chain enhancer (E#). 
However, in Etz-bcl-2 transgenic mice, a proportion of thymo- 
cytes with reactivity against self-superantigens appeared  to 
have survived deletion in the thymus (20,  21). 
To further evaluate the role of Bcl-2 in T cell development, 
the  lck1"r-bcl-2 transgenic mice were  mated with  the H-Y 
TCK transgenic mice, which expressed on a majority of their 
T  cells a TCR that is specific for the male (H-Y) antigen 
presented by the H-2D b class I molecule (22, 23). We found 
that in doubly transgenic female lckPr-bcl-2/H-Y  TCR mice 
1 Abbreviations used in this  paper: AICD, activation-induced  cell death;/ckP~, 
proximal promoter of kk; PCD, programmed cell death. 
of the 1-1-2  b (selecting) haplotype, the repertoire  of positively 
selected CD4-8 § T  cells was dramatically altered.  In con- 
trast,  negative selection  of CD4 +8 + H-Y TCR + thymo- 
cytes was unaffected in 1-1-2  b doubly transgenic male mice. 
We also examined the normal developmentally regulated ex- 
pression of the endogenous bcl-2 gene in thymocyte subpopu- 
lations and the effect of positive selection on bcl-2 expression. 
Materials and Methods 
Mice.  C57B1/6  mice were purchased from The Jackson Labo- 
ratory (Bar Harbor, ME). t-1-2  b H-Y TCK,  1-1-2  d H-Y TCK, and 
kkr~-bcl-2 transgenic mice were produced as previously described 
(19, 22, 23). 
Antibodies.  PE-labeled anti-CD4 (GK 1.5), FITC-labeled, or 
biotinylated anti-CD8 (53-6.7) mAbs were purchased from Becton 
Dickinson (Mississauga, ON,  Canada). Anti-H-2D b (H141-31) 
mAb was purchased from Bioproducts for Science (Indianapolis, 
IN) and FITC-labeled sheep anti-mouse Ig was purchased from 
Silenus Laboratories  (Hawthorne, Australia). mAbs specific  for the 
transgenic TCR ~ chain, F23.1, and the transgenic TCR c~ chain, 
T3.70, were prepared as previously described (23-25). 
Flow Cytometry.  Two-color  staining of cells with FITC-labeled 
anti-CD8 and PE-labeled anti-CD4 mAb was performed  as described 
(23). Three-color analysis was used to determine the expression 
of a specific  cell surface marker by CD4+8 + thymocytes as previ- 
ously described (6). Briefly,  thymocytes were first incubated with 
the mAb that is specific for the marker of interest. This was fol- 
lowed by incubation  with FITC-labeled  sheep anti-mouse Ig, normal 
mouse serum, PE-labeled anti-CD4 mAb, biotinylated anti-CD8 
mAb, and finally,  by Streptavidin-Tandem  (Southern Biotechnology 
Associates, Birmingham, AL). The labeled  cells were analyzed  with 
a FACScan  |  flow cytometer equipped with a single argon laser 
(Becton Dickinson). For three-color analysis, 25,000 events were 
collected per sample and the data was analyzed using FACScan  | 
Research Software (Becton Dickinson). 
Purification of Thymocyte  Subpopulations.  CD4-8-  thymocytes 
were isolated according to the following procedure. Thymocytes 
were incubated with IMDM plus 10% FCS with cytotoxic anti- 
CD4 (RL 172) (26) and anti-CD8 (HO 2.2) (27) mAbs for 40 
rain on ice. The cells were washed once and incubated with Low- 
Tox-M rabbit complement (Cedarlane  Laboratories, Hornby, ON, 
Canada) 1:10 dilution for 45 rain at 37~  Dead  cells were removed 
by centrifugation over Histopaque 1077 (Sigma Chemical Co., St. 
Louis, MO). Viable cells from the interface  were collected,  washed 
twice, and incubated in IMDM plus 10% FCS with the GK 1.5 
(anti-CD4) mAb and the 53-6.7 (anti-CD8) mAb for 20 rain on 
ice.  Sheep anti-mouse  IgG-coated Dynabeads (Dynal,  Oslo, 
Norway) were then added to the cell suspension and incubated  with 
rotation for 40 rain at 4~  Cells that were bound to Dynabeads 
were removed with a magnet. The purity of the remaining cells 
was determined by two-color staining with FITC-labeled  anti-CD8 
and PE-labeled anti-CD4 mAbs. CD4+8 § and CD4§  -  thymo- 
cytes were isolated  by staining thymocytes  with FITC-labeled  anti- 
CD8 and PE-labeled anti-CD4 mAbs followed by two-color cell 
sorting using the FACStar Plus  |  cell sorter (Becton Dickinson). 
For the isolation of CD4 +8 + thymocytes  expressing either low or 
high levels of the transgenic TCR/3 chain, thymocytes were in- 
cubated with biotinylated anti-CDS, PE-labeled anti-CD4,  and 
FITC-labeled anti-F23.1 mAbs followed  by Streptavidin Cychrome 
(PharMingen, distributed by Cedarlane  Laboratories). Three-color 
sorting was performed with the FACStar Plus  |  cell sorter. 
146  Regulation  of the T Cell Repertoire Selection by bcl-2 mRNA  Quantitation  by PCR.  RNA was extracted from 3  x 
10s-2  x  106  purified  thymocyte  subpopulations  using  the 
guanidinium isothiocynate method as described (28). Serial dilu- 
tions (10-fold) of this RNA were used as templates for a cDNA 
synthesis reaction. Bcl-2 and/~-actin mRNA levels  were then evalu- 
ation  by quantitative  reverse transcriptase PCR using  p(dN)6 
random primers and the GeneAmp RNA PCR Kit (Perkin Elmer 
Cetus, Norwalk, CT). Reverse transcriptase PCR was performed 
according to  the  manufacturer's procedure.  Primers used for 
amplification  were o!igonucleotides  recognizing sequences in bcl-2 
(5'-CCTGTGCCACCATGTGTCCATC-Y and 5'-GCTGAGAAC- 
AGGGTCTTCAGAGAC-Y), and ~-actin (~-actin A and B) (29). 
All  primers were used in  the  same PCR  reaction  mixture. 
Amplification conditions were 96~  for 1.5 rain followed by 22 
cycles of 96~  for 45 s, 58~  for 2 min, and 72~  for 1 min. After 
amplification, 10/zl of PCR. products were run on 1.5% agarose 
gel and transferred to nylon membranes (Gene Screen Plus, Du 
Pont, Mississauga, ON, Canada). Radioactive probes were made 
using random priming (30), and the filters were hybridized with 
the mixture of 3~p-labeled probes specific  for bcl-2 and/~-actin. The 
filters were then washed and autoradiographed with intensifying 
screens at  -70~ 
Results 
CD4-8 +  Thymocytes from Doubly H-Y  TCR/bcl-2  Trans- 
genic Mice Possess an Altered TCR Repertoir~  Transgenic mice 
in which a TCR of defined antigenic specificity is expressed 
by a majority of T  cells have served  as useful models for 
analyzing the mechanisms of positive and negative selection 
(2). We have used the H-Y TCR transgenic mice as our model 
system. In these mice the transgenic TCR., specific for the 
male (H-Y) antigen presented by H-2D  h, is under the tran- 
scriptional control of endogenous enhancers (2). Among im- 
mature CD4- 8- and CD4 +  8 + thymocytes, the TCR prod- 
ucts expressed are almost exclusively of transgenic origin. In 
female 1-1-2  ~ transgenic mice, the transgenic TCtL is posi- 
tively selected by thymic epithelial cells that present H-2D  b 
class I molecules in association with self-peptides of undefined 
structure (23,  31, 32).  The net result of this positive selec- 
tion process is the overproduction of CD4-8 + thymocytes 
that almost exclusively express the transgenic TCR. Whereas 
there is no suppression  of production of mature CD4 +  8- 
thymocytes, the production of these cells in female transgenic 
mice requires  the use of endogenous TCR a  chains (2, 23). 
To better understand the effect of the bcl-2 gene in positive 
selection, we mated the H-Y TCR transgenic mice with the 
kkP~-bcl-2  transgenic  mice  to  produce  doubly  transgenic 
mice. Positive selection in female doubly transgenic mice was 
followed by determining the percentages of thymocytes with 
the four CD4/CD8 phenotypes, as well as the composition 
of the TCR expressed by these thymocyte subsets. As shown 
in Fig.  1,  42%  of the thymocytes in female H-2  b doubly 
transgenic mice are of the CD4- 8 + phenotype. This repre- 
sents  a 3.5-fold increase  in CD4-8 + thymocytes as com- 
pared with the single H-Y TCR transgenic littermate. In 
contrast, 21% of the thymocytes are of the CD4+8 -  pheno- 
type in the doubly transgenic mice, compared with the 14% 
observed for single H-Y TCR transgenic littermates. Similar 
results were observed for three other sets of single H-Y TCtL 
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Figure  1.  Alteration  of the repertoire of CD4+8  + thymocytes  and 
CD4-8 + thymocytes  in H-Y TCR/bcl-2 doubly  transgenic  mice. Thymo- 
cytes from female  H-2  b H-Y TCK or female  H-2  b H-Y TCK/bd-2 doubly 
transgenic  mice  were harvested  and triple-stained  with the indicated  mAbs. 
The level of the transgenic  TCK ~ chain (detected  by the F23.1 mAb) 
or transgenic TCR ot chain (detected  by the T3.70 mAb) expressed by 
CD4+8 + thymocytes  and by CD4-8 + thymocytes  from these two types 
of mice are as indicated. 
and doubly transgenic mice. Thus, a major effect of the bcl-2 
transgene in doubly transgenic mice is the further skewing 
of thymocytes towards the CD4-8 + lineage. 
Three-color staining of thymocytes  with mAbs specific for 
CD4, CD8, and either the transgenic TCR/3 (detected by 
the F23.1  mAb) or ot (detected by the T3.70 mAb) chain 
allowed us to determine the level of transgenic TCR/3 or 
ot chain expressed by the four thymocyte subsets defined on 
the  basis  of their  CD4/CD8  phenotypes.  As  previously 
reported,  and shown here in Fig.  1,  CD4+8 + thymocytes 
from female H-2 b TCR transgenic mice expressed primarily 
the transgenic TCR heterodimer. It can also be deduced from 
Fig.  1 that a small percentage of CD4+8 + thymocytes from 
147  Tao et al. H-Y TCR transgenic mice expressed a high level of the trans- 
genic TCR heterodimer (6, 33). CD4+8 + thymocytes from 
doubly transgenic  mice also expressed primarily  the trans- 
genic TCR heterodimer.  However, it is clear that although 
a greater proportion of CD4 +8 + thymocytes from doubly 
transgenic mice expressed a high level of the transgenic TCR 
13 chain,  only a fraction of these cells also expressed a high 
level of the transgenic TCR o~ chain. Furthermore, a smaller 
proportion of CD4 +8 + thymocytes from doubly transgenic 
mice was found to express intermediate levels of the trans- 
genic TCK o~ chain when compared with single H-Y TCR 
transgenic littermates.  This was accompanied by an increase 
in the proportion of CD4 § 8 + thymocytes that express very 
low levels of the transgenic  TCR ot chain.  These cells pre- 
sumably expressed higher levels of endogenous TCR ot chains 
which  were not  stained by the T3.70  mAb.  This bias to- 
wards endogenous TCR c~ usage by CD4 § 8 + thymocytes is 
also reflected in the TCR composition of mature CD4-8 + 
thymocytes in  the  doubly transgenic  mice.  As previously 
reported, CD4-8 § thymocytes from H-2  ~ female H-Y TCR 
transgenic  mice primarily express the transgenic  TCK het- 
erodimer (23 and Fig. 1). In contrast, more than half of the 
mature  CD4-8 +  thymocytes from  the  doubly transgenic 
mice expressed transgenic TCR B chain in association with 
high levels of endogenous TCR c~ chains,  which were not 
detected by the T3.70 mAb. This skewing towards the CD8 
lineage was not as pronounced in the LN of doubly trans- 
genic mice and was only reflected by a slight increase in the 
proportion  of CD4-8 +  T  cells.  The  LN  of these doubly 
transgenic mice contained 26.3  _+  0.4%  (n  =  3)CD4-8 § 
T  cells compared with 17.0  _+ 0.5% (n  =  5) in H-Y TCR 
transgenic  mice.  However, the proportion  of CD4-8 §  T 
cells in the LN of H-Y TCR or doubly transgenic mice ex- 
pressing high levels of the transgenic TCR was approximately 
the  same (about  15%). 
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Figure  2.  Overproduction  of  CD4-8 +  thymocytes  in  1t-2  d  H-Y 
TCR/bcl-2  doubly transgenic  mice. H-2  a H-Y TCR/bcl-2  doubly trans- 
genic mice were produced by crossing bcl-2 transgenic mice and H-Y TCR 
transgenic  mice onto a 1-1-2  a background.  The lack of H-2D  b expression 
by these mice was confirmed by staining with the anti-H-2D  b mAb (data 
not shown). Thymocytes from these mice were double-stained  with PE- 
labeled anti-CD4 and FITC-labeled  anti-CD8 mAbs and analyzed in the 
FACScan  |  flow cytometer. 
We next  determined  whether  this  skewing towards the 
CD4-8 § lineage in the doubly transgenic mice was depen- 
dent  on the interaction  of the transgenic  TCR. with posi- 
tively selecting ligands in the thymus.  We have previously 
shown that the transgenic TCK confers no selective advan- 
tage in mice of the H-2 d haplotype (23). Doubly transgenic 
mice of the H-2  d haplotype were produced by backcrossing 
the bcl-2 and H-Y TCR transgenes onto a H-2  d background. 
As shown in Fig.  2,  CD4-8 §  thymocytes were also over- 
produced by 3.5-fold in female H-2  d doubly transgenic mice. 
Thus,  overproduction  of CD4-8 +  thymocytes  in  doubly 
transgenic  mice is independent  of interaction  of the trans- 
genic TCR with its positively selecting ligand(s) in the thymus. 
Negative  Selection  Occurs  Efficiently  in  H-Y  TCR/bcl-2 
Double  Transgenic Male Mice.  It was previously shown that 
CD4 +8 + thymocytes expressing the H-Y TCR. were deleted 
efficiently in  male H-2 b mice (22).  To determine whether 
these cells were protected from deletion by Bcl-2, the H-Y 
TCR transgenic mice were mated with lcker-bcl-2 transgenic 
mice to produce doubly transgenic  offspring.  Thymocytes 
and LN cells  were harvested from doubly transgenic  male 
mice and their CD4/CD8 phenotypes determined by two- 
color analysis. Two phenotypes of doubly transgenic  male mice 
were observed. The first phenotype is similar to that of the 
single H-Y TCR transgenic male mice and is shown in Fig. 3. 
Doubly transgenic  males with  this phenotype have a very 
prominent  CD4-8-  population and poorly defined popula- 
tions  of CD4 § 8 +,  CD4-8 +,  and  CD4 +8-  thymocytes. 
Previous studies (22, 34) have determined that this phenotype 
is a consequence of the efficient deletion of CD4+8 + thymo- 
cytes expressing  the  H-Y TCR.  The  efficient deletion of 
CD4 +  8 + thymocytes is reflected in greatly reduced thymo- 
cyte cell yields (19  x  106  ___ 6  x  106, n  =  6 for H-Y TCR 
males versus 45  x  106  _  5  x  106, n  =  3 for doubly trans- 
genic males). It is also reflected in the poor development of 
CD4+8 -  T ceils and the presence of a prominent  CD4-81~ 
population in the LN (22, 34, and Fig. 3). The second pheno- 
type  is  shown  in  Fig.  4.  In  this  instance,  deletion  of 
CD4 +8 + thymocytes in doubly transgenic males is incom- 
plete. The number of thymocytes recovered from doubly trans- 
genic males was similar to that of normal mice (112  x  106 
__  11  x  106, n  =  3). However, a large fraction of surviving 
CD4 +  8 + thymocytes from doubly transgenic males did not 
express the transgenic TCK ot chain despite having high and 
uniform expression of the transgenic TCK/~ chain (Fig. 4). 
Thymocytes from H-Y TCK transgenic males surviving de- 
letion were large cells, as defined by the forward scatter pa- 
rameter, and expressed high levels of the transgenic TCR het- 
erodimer.  In  contrast,  the  vast  majority  of  thymocytes 
recovered from doubly transgenic males were small cells and 
of these, a majority was not stained by the T3.70 mAb (Fig. 4). 
Thymocytes and LN cells  recovered from doubly trans- 
genic male mice, with either of the phenotypes described in 
Figs.  3 and 4, are functionally tolerant to the male antigen 
as they do not respond to male H-2  b APC, even in the pres- 
ence of an excess amount of exogenously added JL-2 (data 
not  shown). 
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Positive  Selection  of CD4  + 8 +  Thymocytes  Is Associated  with 
Increased  bcl-2  Expression.  It  was  previously  shown  that 
whereas bcl-2 is expressed at high levels by mature medullary 
thymocytes, only occasional cortical thymocytes express bcl-2 
(18).  It is not known whether immature CD4-8-  thymo- 
cytes express bcl-2,  or whether the commitment of CD4+8 + 
thymocytes to the PCD pathway is associated with the cessa- 
tion of Bcl-2 production.  It is also not known whether the 
rescue of CD4 +8 +  thymocytes from the PCD  pathway by 
positive selection signals is associated with the reexpression 
of bcl-2  in these cells. To address these questions,  we deter- 
mined  bcl-2  mRNA  levels  in  immature  CD4-8-  and 
CD4+8 + thymocytes, as well as in mature CD4+8 -  thymo- 
cytes  from  female  H-2 b  H-Y  TCR  transgenic  mice,  or 
normal  H-2 ~  mice,  by  quantitative  reversed  transcriptase 
PCR. The results of one of three representative experiments 
are shown in Fig.  5.  CD4-8-  thymocytes from both H-Y 
TCR transgenic and normal mice expressed a high level of 
the bcl-2 mRNA. Densitometric measurements indicate that 
this level of bcl-2 mRNA  expression was downregulated  by 
Figure  3.  Effacient deletion of autospecific CD4+8 + thymocytes in 
H-Y TCR/bd-2  doubly transgenic mice. Thymocytes and LN cells from 
male 1-1-2  b H-Y TCR and male H-2 b H-Y TCR/bcl-2  doubly transgenic 
mice were collected, double-stained with anti-CD4 and anti-CD8 mAbs, 
and analyzed in the FACScan  | 
Male  thymocytes 
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Figure  4.  A large proportion of 
CD4+8 +  thymocytes  escaping 
negative selection  in H-Y "rCR/bcl-2 
doubly transgenic male mice express 
endogenous TCR a  chains. Thy- 
mocytes from male H-2~ H-Y TCR 
transgenic mice and male 1-1-2  b H-Y 
TCR/bd-2  doubly transgenic mice 
were  collected and  triple-stained 
with mAbs specific  for CD4, CD8, 
and either the transgenic TCR. 13 or 
the transgenic TCR c~ chain and 
analyzed in the FACScan  | 
149  Tao et al. Figure  5.  Differential expression of  bcl-2 by  immature  CD4-8-, 
CD4+8 +,  and mature CD4+8 -  thymocytes. CD4-8-  thymocytes of 
98%  purity were prepared as described in Materials and Methods. 
CD4+8 + and CD4+8 -  thymocytes of/>95% purity were obtained by 
two-color staining with anti-CD4 and anti-CD8 mAbs followed by cell 
sorting. Total  cellular  RNA was extracted  from the indicated  purified  popu- 
lations, and 10-fold dilutions of these KNAs were used as templates in 
a cDNA synthesis  reaction.  The coamplification  was performed  with mixed 
bcl-2 and/~-actin primers, and the Southern blots of the PCR products 
were hybridized with the 32p-labeled  probes specific  for bcl-2  and jS-actin. 
The sizes  of the PCR coamplified  transcript fragments of bcl-2  and B-actin 
are 405 bp and 570 bp, respectively.  (A) Purified thymocyte subpopula- 
tions from female 1-1-2  b H-Y TCR transgenic mice. (13) Purified thymo- 
cyte subpopulations from C57B1/6 mice. 
pressing low levels of the transgenic TCR/5  chain.  A  2.0- 
fold increase was  observed in  a  repeat  experiment. 
Discussion 
Bcl-2 Participates in T  Cell Development.  Our results show 
that thymus-specific expression of a bcl-2 transgene favors the 
development  of thymocytes of the  CD4-8 §  lineage.  This 
skewing  towards  the  CD4-8 §  lineage  occurs not  only in 
bcl-2 transgenic mice but also in H-Y TCR/bcl-2 doubly trans- 
genic mice, regardless of whether the H-Y TCR is expressed 
in  a  selecting  1-1-2  b  or  a  nonselecting  H-2  d  environment. 
Thus, the further skewing towards the CD4-8 + lineage ob- 
served in H-Y TCR transgenic mice appears to be indepen- 
dent of the antigen specificity of the transgenic TCK.  This 
is  consistent  with  the  observation  that  a  large proportion 
of CD4-8 + thymocytes produced in 1-1-2  ~ H-Y TCR/bcl-2 
doubly transgenic female mice expressed endogenous TCR 
c~ chains rather than the transgenic TCR oe chain. The bias 
towards the CD8 lineage is not as apparent in peripheral T 
5.1- and  7.2-fold in CD4+8 +  thymocytes from H-Y TCR 
transgenic  mice  and  normal  mice,  respectively.  Mature 
CD4 § 8-  thymocytes from both H-Y TCR transgenic mice 
or  normal  mice  upregulated  bcl-2  mRNA  expression  by 
3.8-  and  7.7-fold,  respectively,  when  compared  with  im- 
mature  CD4+8 §  thymocytes.  By normalizing  the level of 
bcl-2 mRNA  expressed by CD4 +  8 +  thymocytes to that  of 
B-actin mKNA,  it was found that the level of bcl-2 mRNA 
expressed by these cells from H-Y TCK transgenic mice was 
about 1.6-fold higher as compared with the same thymocyte 
subpopulation from normal mice. It is conceivable that the 
slightly  higher  expression  of  bcl-2  mRNA  in  CD4+8 § 
thymocytes from H-Y TCK transgenic mice was due to the 
larger number of thymocytes in H-Y TCR transgenic mice 
that  had received positive selection signals.  To test this  hy- 
pothesis,  we  triply  stained  thymocytes  from  female  H-2 b 
H-Y TCK transgenic mice with mAbs specific for CD4, CD8, 
and  the transgenic TCK/3 chain,  and  sorted for CD4 +  8 + 
thymocytes expressing either low or high levels of the trans- 
genic TCR/5  chain.  As shown in Fig.  6  CD4 +  8 +  thymo- 
cytes from H-Y TCR transgenic mice expressing high levels 
of the transgenic TCR/5 chain expressed a level of bcl-2 mRNA 
that  was  1.9-fold  higher  than  CD4+8 +  thymocytes  ex- 
Figure 6.  Coordinate  upregulation  of  TCR expression  and bcl-2  mRNA 
by CD4+8 + thymocytes. Thymocytes from 1-1-2  b H-Y TCK transgenic 
mice  were harvested  and triple stained  with anti-CD4, anti-CDS, and anti- 
transgenic TCR ~ chain mAbs. CD4 +  8 + thymocytes expressing either 
a low or high level of the transgenic TCK B chain were isolated by cell 
sorting. >195% of the sorted cells were of the CD4+8 + phenotype. (A) 
Quantitative reversed transcriptase PCR for bcl-2 mRNA expression  by 
the TCR  hi and TCR  lo CD4+8 + thymocyte populations was determined 
as described  in Materials and Methods and in Fig. 5. (/3) (Open andfilled 
histograms) Low and high expression,  respectively,  of the transgenic TCR 
chain by the sorted CD4 §  8 § thymocytes. 
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increase in the proportion of mature CD4- 8 + T cells, there 
is no evidence of increased usage of endogenous TCtk ct chains. 
However, this observation does not imply that CD4-8 + T 
cells selected under the influence of the bcl-2 transgene are 
abnormal since previous studies (2, 35) have shown that the 
peripheral T cell repertoire is shaped by mechanisms distinct 
from those operative in the thymus. In contrast, high levels 
of bcl-2 expression in CD4+8 + thymocytes expressing the 
H-Y TCR fails to protect them from deletion by deleting 
ligands present in male TCR transgenic mice. In doubly trans- 
genic mice that have high thymocyte cell numbers, the in- 
crease in cell numbers was due to the increased production 
of small CD4+8 + thymocytes that did not express the male- 
specific TCR.  We found that immature CD4-8-  thymo- 
cytes expressed a high level of bcl-2 mRNA. This is consis- 
tent with a recent report (36) where these cells were shown 
to express a high level of the Bd-2 protein.  The low level 
of bcl-2 mRNA in CD4+8 §  thymocytes expressing a low 
TCR level and the higher level of bcl-2 mRNA in CD4 +  8 + 
thymocytes expressing a high level of TCR is consistent with 
the model that the commitment of CD4 +  8 + thymocytes to 
the PCD pathway is associated with the downregulation of 
bcl-2 mtkNA, and that rescue from this PCD pathway by 
positive selection signals is associated with the upregulation 
of bcl-2 mRNA. However, this conclusion is in contrast with 
that obtained from a recent study with bcl-2 homozygous 
mutant chimeric mice where it was shown that bcl-2 was not 
required for T  cell development (37).  Thus, a more likely 
explanation of our data is that the developmentally regulated 
expression of bcl-2 is a result, and not the cause,  of T  cell 
developmental processes. Importantly, the expression of bcl-2 
is required for the survival of mature T  cells in peripheral 
lymphoid organs (37), a conclusion consistent with the rein- 
duction of bet-2 expression in positively selected CD4-8 + T 
cells observed in our study. 
Model to Account for Bias  Towards the CD4-8 + Lineage in 
bcl-2 Transgenic Mice.  The observed bias towards the matu- 
ration of cells of the CD4-8 + lineage in the bcl-2 transgenic 
mice contrasts with T cell development in normal mice, where 
the development of CD4 +  8- thymocytes is favored over that 
of CD4-8 + thymocytes. We propose that this bias towards 
the CD4-8 + lineage in bcl-2 transgenic mice is due in part 
to differences in signaling efficiency  between CD4 and CD8 
coreceptor molecules during the positive selection process. 
In the H-Y TCR transgenic model system, we have shown 
that the CD8 molecule functions as a coreceptor in the posi- 
tive selection of CD4-8 + thymocytes expressing the H-Y 
TCR (38).  Although it remains to be demonstrated, posi- 
tive selection of CD4 +  8-  thymocytes expressing  MHC class 
II-restricted TCR may also be dependent on CD4 molecules 
that serve a coreceptor function. Previous studies (39) have 
shown that the cytoplasmic domain of CD4 interacts with 
a higher a~nity with p56 ~  than does the cytoplasmic do- 
main of CDS.  This less efficient association of p56 ~  with 
CD8 may contribute to a reduction in efficiency of positive 
selection  of CD4-8 +  thymocytes expressing  MHC  class 
I-restricted TCR.  Since the life span of CD4+8 + thymo- 
cytes is increased in bcl-2 transgenic mice, this may compen- 
sate  for  the  relatively  inefficient  selection  of  CD4+8 + 
thymocytes expressing MHC class I-restricted TCR. In con- 
trast, as a result of efficient signaling mediated by the CD4 
coreceptor molecule, CD4 +  8 + thymocytes expressing MHC 
class  II-restricted TCR  are probably  selected at  a  higher 
efficiency,  and the increased life span of CD4 +  8 + thymo- 
cytes as a result of transgenic bcl-2 expression is thus less likely 
to contribute to positive selection in these cells. 
Explanation for the Preferential Usage of Endogenous  TCR 
t~ Chains by CD4 Thymocytes.  The preferential usage of en- 
dogenous TCR ot chains by CD4-8 + thymocytes from fe- 
male H-2 b H-Y TCR/bcl-2 doubly transgenic mice may be 
related to the low affinity of the H-Y TCR for the positively 
selecting ligand.  Experimental upregulation  of the  CD8 
coreceptor and its effect on positive selection of immature 
CD4+8 +  thymocytes expressing  the  H-Y  TCR  suggests 
that this is a low affinity TCR (40, 41). Recent studies (42, 
43) suggest that CD4 +8 + thymocytes can continue to rear- 
range their endogenous TCR c~ genes until they receive posi- 
tive selection signals. As CD4 +  8 + thymocytes from doubly 
transgenic mice survive longer, it is likely that they will have 
a higher probability of generating TCR t~ chains able to pair 
with the transgenic TCR/5 chain more efficiently than the 
transgenic ot chain. Some of these transgenic 3/endogenous 
o~ TCR heterodimers may have a higher affinity for positively 
selecting ligands than the H-Y TCR, and thus have a selec- 
tive advantage over the H-Y TCR. This would lead to the 
production of a large number of CD4-8 + thymocytes ex- 
pressing high levels of endogenous TCR o~ chains in the doubly 
transgenic females. The validity of this model can be tested 
further by mating bcl-2 transgenic mice with transgenic mice 
expressing TCR with putatively higher affinities for class I 
selecting ligands, or with transgenic mice that express a class 
II-restricted TCR. 
Bcl-2  Overexpression Does  Not  Inhibit  Negative  Selection. 
Previous studies (19) have shown that Bcl-2 does not confer 
resistance to deletion of self-reactive T  cells bearing certain 
V3 regions that are specific for self-superantigens presented 
in the context of certain MHC class II molecules. However, 
depending on the promoters used to regulate expression of 
the bcl-2 transgene, some protection of T cells against dele- 
tion by self-superantigens was observed (20,  21).  Superan- 
tigens differ from conventional peptide antigens in several 
ways.  Conventional  peptide  antigens  are  processed  and 
presented in the antigen-binding groove of MHC class I or 
II molecules, and are recognized by combinatorial elements 
of the TCR heterodimer (44).  Superantigens, on the other 
hand, do not require conventional antigen processing, are not 
MHC haplotype restricted (although they require presenta- 
tion by MHC class II), and interact primarily with the V3 
portion of the TCR (45, 46).  Thus,  superantigen-reactive 
T  cells may differ from T  cells that are reactive to conven- 
tional peptide-MHC complexes in terms of their activation 
or their negative selection, requirements. Furthermore, the 
deletion of T cell precursors specific for superantigens occurs 
151  Tao et al. at a later developmental stage, apparently after the CD4 +  8 § 
thymocytes have been committed to the CD4 or CD8 lineages 
(47).  It was suggested that the lack of protection of super- 
antigen-reactive T cells in lckPr-bcl-2 transgenic mice, when 
compared with other bcl-2 transgenic mice that used other 
promoters to drive the bct-2 transgene, could be due to the 
downregulation of the activity of the proximal Ick promoter 
in  mature  thymocytes (21). In  this  study, we  show  that 
CD4 +8 § thymocytes expressing the H-Y TCR are deleted 
efficiently  despite high levels of bcl-2 expression in these cells. 
This suggests that AICD that is brought about by negative 
selection signals occurs independently of Bcl-2. In contrast, 
high Bcl-2 levels in CD4 +8 + thymocytes favor development 
along the CD8 lineage pathway. The differential sensitivity 
of these two developmental processes in the thymus to high 
levels of bcl-2 expression may provide a unique means to ana- 
lyze the signaling mechanisms associated with these processes. 
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